Finance

Beta
Lists
054050:KOSDAQ
NH NongwooBio Co Ltd
â‚©7,140.00
+2.59%
(+180.00) 1D
Jun 11, 3:30:20 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 054050...
Open
â‚©6,960
High
â‚©7,150
Low
â‚©6,910
Mkt. cap
114.46B
Avg. vol.
50.42K
Volume
20.07K
Dividend
3.50%
Quarterly dividend
â‚©62
Ex-dividend date
Dec 27, 2023
P/E ratio
9.34
52-wk high
â‚©9,200
52-wk low
â‚©6,610
EPS
â‚©764
Shares outstanding
16.03M
No. of employees
333
Open
â‚©6,960
High
â‚©7,150
Low
â‚©6,910
Mkt. cap
114.46B
Avg. vol.
50.42K
Volume
20.07K
Dividend
3.50%
Quarterly dividend
â‚©62
Ex-dividend date
Dec 27, 2023
P/E ratio
9.34
52-wk high
â‚©9,200
52-wk low
â‚©6,610
EPS
â‚©764
Shares outstanding
16.03M
No. of employees
333
News stories
From sources across the web
About NH NongwooBio Co Ltd
CEOPark Dong-seop
Employees333
Founded1967
Headquarters-
SectorFood
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
43.35B
38.88B
39.18B
36.37B
Cost of goods sold
22.34B
20.38B
23.57B
15.84B
Cost of revenue
22.34B
20.38B
23.57B
15.84B
Research and development expenses
4.70B
4.45B
4.62B
4.11B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.66B
9.31B
10.94B
9.88B
Operating expense
17.80B
14.77B
16.47B
15.16B
Total operating expenses
40.14B
35.15B
40.03B
31.00B
Operating income
3.20B
3.73B
-850.69M
5.37B
Other non operating income
311.66M
-226.19M
-308.26M
-256.58M
EBT including unusual items
2.82B
4.77B
-713.94M
6.66B
EBT excluding unusual items
1.23B
4.29B
-471.94M
6.66B
Income tax expense
238.24M
471.57M
338.02M
250.23M
Effective tax rate
8.43%
9.89%
-47.34%
3.76%
Other operating expenses
329.00M
119.00M
230.00M
148.00M
Net income
2.49B
4.30B
-958.39M
6.42B
Net profit margin
5.74%
11.07%
-2.45%
17.64%
Earnings per share
-
-
-
-
Interest and investment income
206.00M
239.00M
229.00M
176.00M
Interest expense
-262.00M
-237.00M
-249.00M
-249.00M
Net interest expenses
-56.00M
2.00M
-20.00M
-73.00M
Depreciation and amortization charges
1.03B
812.00M
682.00M
960.00M
EBITDA
5.03B
5.17B
734.48M
7.11B
Gain or loss from assets sale
-1.68B
-379.98M
-35.74M
2.33M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more